No slide title

*All info as at 31 May 2009 unless otherwise stated.
GOLDEN WORLDWIDE EQUITY FUND (Easi-Investor)
FACTSHEET – May 2009
Asset Allocation*
Fund Objective
The Fund (feeding into UOBAM United International Breakdown by Country (in %)*
Growth Fund) seeks to achieve long-term capital appreciation and regular income through investing in shares of companies listed on global emerging and Fund Performance (S$ Bid-to-Bid returns)
Top Ten Holdings (in %)*
Jan- Jan- Jan- Jan- Jan- Jan- Jan- Jan- Jan- Fund Manager’s Comments
The Fund adopted a two-pronged strategy of overweighting Emerging Markets as well as focusing more on defensive sectors in a challenging operating environment for the business. This helped the first quarter’s fund performance. The negative contributors on the performance were mainly financials which includes Bank of America, Citigroup, KDDI, Allied Irish Bank and US Bancorp. The positive contributors to the performance were Petrobras, Potash Corporation, Apple Computer, Autonomy Corporation and BHP Billiton. In terms of asset allocation, we continue to overweight Emerging Markets, especially Latin America and we have overweight positions in the US and Asia at the expense of Europe, Japan and Australia. The Fund continues to adopt a more defensive strategy in terms of stock selection, and continues to overweight more stable sectors including Consumer Staples, Healthcare, Telecommunications and Utilities. However, these Fund’s sector biases are less Source: Lipper • Performance are in SGD as at 31 May 09 •
pronounced due to opportunities in some of the higher risk Performance figures for 1 mth till 1 yr show the % change,
sectors. The Fund’s exposure to Financials was lifted closer to those exceeding 1 yr show the average annual compounded
neutral, but this is mainly via exposure in Emerging Markets and the US, not Europe or Japan. Given the view that operating conditions will remain challenging through 2009, the Fund The CPF interest rate for the Ordinary Account (OA) is based on the 12-month fixed deposit and month- continues to focus on high-quality businesses across all sectors end savings rates of the major local banks. Under the CPF Act, the Board pays a minimum interest of 2.5% p.a. when this interest formula yields a lower rate. From 1 Jan 08, the new interest rate for the and are more inclined towards stable growth sectors. Financial Special, Medisave & Retirement Accounts (SMRA) will be pegged to the yield of 10-year Singapore market conditions improved towards the later stage of the first government bond plus 1%. For 2008 and 2009, the minimum interest rate for the SMRA will be 4% p.a. After 2009, the 2.5% p.a. minimum interest rate, as prescribed by the CPF Act, will apply to SMRA. In quarter 2009, setting the stage for a market rally. However, the addition, from 1 Jan 08, the CPF Board will pay an extra interest of 1% per annum on the first $60,000 of Fund continues to adopt a risk-averse strategy given the a CPF member’s combined balances, including up to $20,000 in the OA. From 1 April 08, the first $20,000 in the Ordinary Account will not be allowed to be invested under the CPF Investment Scheme. significant headwind that weak growth will present to corporate And from 1 May 09, the first $30,000 in the Special Account will not be allowed to be invested under the profits and profitability. While equities are cosmetically attractive, earnings risk are significant. Key Information
The Straits Times, Business Times, Lianhe Zaobao, www.manulife.com.sg S$5000 (single premium), S$2000 (SRS annual RSP) Important Information: This report is prepared by Manulife (Singapore) Pte Ltd and is provided for information purposes only. Past performance is not necessarily a guide to future performance.
Manulife (Singapore) Pte Ltd. A Manulife Financial company. Reg. No. 198002116D 491B River Valley Road #07-00 Valley Point Singapore 248373 Tel: 6737 1221 Fax: 6737 8488 Website: www.manulife.com.sg

Source: http://manulife.c3.com.sg/pdfs/FP_ILP_EI_Golden_Worldwide_Equity_Fund.pdf

Microsoft word - article in alternative therapies.doc

Transdermal Progesterone Cream as an Alternative Progestin in Hormone Therapy Alternative Therapies in Health and Medicine Nov/Dec 2005. Vol 11, No. 6; 36-38. Helene B. Leonetti, MD; Jennifer Landes, DO; David Steinberg, MD; James N. Anasti, MD Abstract Objective: To evaluate the endometrial effects and determine patients’ acceptance of transdermal progesterone cream compared to stan

Copyright © 2008-2018 All About Drugs